Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.080
+0.050 (1.65%)
At close: Mar 28, 2025, 4:00 PM
3.230
+0.150 (4.87%)
After-hours: Mar 28, 2025, 6:14 PM EDT
Genelux Revenue
In the year 2024, Genelux had annual revenue of $8.00K, down -95.29%.
Revenue (ttm)
$8.00K
Revenue Growth
-95.29%
P/S Ratio
14,358.50
Revenue / Employee
$348
Employees
23
Market Cap
114.87M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GNLX News
- 2 days ago - Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 days ago - Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Genelux Corporation Announces New Chief Financial Officer - GlobeNewsWire
- 3 months ago - Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - GlobeNewsWire
- 5 months ago - Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - GlobeNewsWire
- 5 months ago - Genelux: 2nd Half Of 2025 PRROC Data Is Major Inflection Point - Seeking Alpha
- 5 months ago - Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - GlobeNewsWire
- 6 months ago - Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire